The World Bladder Cancer Patient Coalition (WBCPC) is the first-time people affected by bladder cancer have a force connecting them. Bladder cancer patients, groups, and organisations work together to ensure the best possible outcomes for bladder cancer patients worldwide.
Every year, more than 570,000 people receive bladder cancer diagnosis around the world. For many of them, a diagnosis will be the very first time they hear about bladder cancer. Bladder cancer is forgotten cancer,
With just over a month left before we enter the World Bladder Cancer Awareness Month 2022, we are thrilled to launch the Campaign Toolkit today.
This toolkit provides an introduction to our new campaign this year and many ways to get involved that are right for you. There are easy things to do as an organisation or if you are on your own or part of a group. Everyone is welcome.
The World Bladder Cancer Patient Coalition joins efforts with the European Cancer Organisation and American Society of Clinical Oncology their members, partners and patient groups to share experience, contacts and intelligence in support of cancer patients affected by the war in Ukraine.
Following discussions with the World Health Organisation, EU Commission and the new ASCO–ECO Ukraine Steering Committee,
In this podcast, our Executive Director Alex Filicevas, and Professor of Genitourinary Oncology Dr Tom Powles, share their perspective on the highlights from the European Society for Medical Oncology (ESMO) Congress 2021, by focusing on greater involvement and collaboration with patients and healthcare professionals in leading medical congresses.
Both discussants also reflect on key challenges and opportunities in cancer care moving forward from the COVID-19 pandemic, including restoring and improving care and efficiency of cancer services.
The Global Cancer Coalitions Network (GCCN) is hosting a free virtual event on March 29, at 17:00 CEST, titled “Coalition Connection 3: Sustaining Patient Advocacy Post-Covid”.
Many patient advocacy organizations faced extraordinary challenges during the COVID-19 pandemic, from loss of crucial funding to significant reductions in human resources, both paid and unpaid.
As we look to a post-pandemic future, during the GCCN event you will hear three perspectives from:
• The advocacy world on how patient advocacy organizations coped with those challenges and what ‘silver linings’ they found;
Bladder Cancer. Two words that deliver a devastating impact. Every year, over 570,000 people are diagnosed with bladder cancer around the world, for many, it is the first time they hear of the disease. We must increase awareness of signs and symptoms to look out for and promote acting on them without delay – early diagnosis is key to significant increase in chance of long-term survival and quality of life.
Bladder Cancer Awareness Month 2022 campaign
We are thrilled to announce the brand new campaign for this year:
Don’t Go Red.
The theme of International Women’s Day (IWD) this year is #BreakTheBias – the start of a gender-equal world. This theme calls for a world free of bias, stereotypes and discrimination; one that is diverse, equitable, and inclusive where women can move ahead.
This is an opportunity to stand and advocate for breaking the existing biases and disadvantages that women affected by bladder cancer face today around the world. Although bladder cancer is often considered a disease of men of older age,
Today, the World Bladder Cancer Patient Coalition is delighted to announce that our president, Dr Lydia Makaroff has become a new member of the European Association of Urology Patient Office Board. Her role and mission as a member of the Patient Office will revolve around fostering collaborations between the EAUPatient Office and the European Patient Advisory Group (ePAG), ensuring that patients remain at the centre of all activities and decisions.
The European Association of Urology (EAU) represents the leading authority within Europe on urological practice,
The World Bladder Cancer Patient Coalition supports the Rare Disease Day international campaign that shines a light on rare diseases and advocates for
health equity for all those living with a rare disease.
With about 300 million people living with a rare disease, there is an urgent need to expand research, increase levels of care, approve new therapeutics, and provide access for every patient who wants or needs treatment.
Launched at the All.Can International virtual event on February 23, the new policy blueprint offers a common and broadly applicable framework to support collaborative policy action to improve efficiency in cancer care for better patient outcomes and more sustainable healthcare systems.
Efficient cancer care benefits everyone and it has never been more important. COVID-19 has delayed diagnoses, compromised treatments, and curtailed research – and health systems now face a large backlog of cancer cases.
For general information, information about membership or policy information, please contact the WBCPC Secretariat at info@worldbladdercancer.org
For general information, information about membership or policy information, please contact the WBCPC Secretariat at info@worldbladdercancer.org
